Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -481.05 Thousand | -1.71 Million | -2.36 Million |
| Net Income | -1.78 Million | -1.93 Million | -1.62 Million |
| Depreciation & Amortization | 66.09 Thousand | 139.53 Thousand | 92.83 Thousand |
| Deferred income taxes | 265.24 Thousand | 2533.00 | -6000.00 |
| Stock-based compensation | 83.4 Thousand | 85.92 Thousand | 19.83 Thousand |
| Change in working capital | 136.58 Thousand | -284.27 Thousand | -916.56 Thousand |
| Other non-cash items | 749.16 Thousand | 284.44 Thousand | 68.29 Thousand |
| Investing Cash Flow | - | -7875.00 | -26.05 Thousand |
| Investments in PPE | - | -7875.00 | -170.13 Thousand |
| Acquisitions | - | - | 109.08 Thousand |
| Investment purchases | - | - | 24.53 Thousand |
| Sales/Maturities of investments | - | - | 35 Thousand |
| Other Investing Activities | - | - | -24.53 Thousand |
| Financing Cash Flow | -140.07 Thousand | -140.07 Thousand | 5.78 Million |
| Debt repayment | -120.3 Thousand | -120.3 Thousand | -60 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | -275 Thousand |
| Common Stock Issuance | - | -34.87 Thousand | 6.22 Million |
| Other Financing Activities | -19.77 Thousand | 15.09 Thousand | -99.72 Thousand |
| Accounts receivables | 68.31 Thousand | -56.92 Thousand | - |
| Accounts payables | -76.49 Thousand | -281.76 Thousand | - |
| Inventory | 1802.00 | -38.61 Thousand | -129.23 Thousand |
| Other working capital | 142.96 Thousand | 93.03 Thousand | -787.32 Thousand |
| Cash at beginning of period | 1.87 Million | 3.73 Million | 340.89 Thousand |
| Cash at end of period | 1.3 Million | 1.87 Million | 3.73 Million |
| Capital Expenditure | - | -7875.00 | -170.13 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -572.93 Thousand | -1.85 Million | 3.39 Million |
| Free Cash Flow | -481.05 Thousand | -1.71 Million | -2.53 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -111.64 Thousand | -78.08 Thousand | -1.14 Million | -1.78 Million | -110.56 Thousand | -183.85 Thousand |
| Depreciation & Amortization | 797.00 | 17.97 Thousand | -18.24 Thousand | 66.09 Thousand | 27.97 Thousand | 28.06 Thousand |
| Deferred income taxes | -119.84 Thousand | -45.18 Thousand | 259.44 Thousand | 265.24 Thousand | - | - |
| Stock-based compensation | 50.32 Thousand | 10.76 Thousand | 60.02 Thousand | 83.4 Thousand | - | 9013.00 |
| Change in working capital | -51.87 Thousand | -9543.00 | 20.01 Thousand | 136.58 Thousand | -36.88 Thousand | 119.08 Thousand |
| Other non-cash items | 101.07 Thousand | 45.18 Thousand | 694.48 Thousand | 749.16 Thousand | 23.5 Thousand | 18.23 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 8539.00 | -8539.00 | -34.41 Thousand | -140.07 Thousand | -28.75 Thousand | -66.53 Thousand |
| Debt repayment | -8539.00 | -8539.00 | -34.41 Thousand | -120.3 Thousand | -28.75 Thousand | -33.13 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 17.07 Thousand | - | - | -19.77 Thousand | - | -33.4 Thousand |
| Accounts receivables | 25.39 Thousand | -9139.00 | -5721.00 | 68.31 Thousand | 8898.00 | 65.36 Thousand |
| Accounts payables | -47.9 Thousand | 4227.00 | 30.09 Thousand | -76.49 Thousand | -82.76 Thousand | 6354.00 |
| Inventory | -45.4 Thousand | 6443.00 | -8591.00 | 1802.00 | 2604.00 | 6261.00 |
| Other working capital | 16.04 Thousand | -11.07 Thousand | 4233.00 | 142.96 Thousand | 34.38 Thousand | 41.1 Thousand |
| Cash at beginning of period | 1.23 Million | 1.3 Million | 1.41 Million | 1.87 Million | 1.55 Million | 1.59 Million |
| Cash at end of period | 1.11 Million | 1.23 Million | 1.3 Million | 1.3 Million | 1.41 Million | 1.55 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -122.63 Thousand | -67.42 Thousand | -111.86 Thousand | -572.93 Thousand | -137.58 Thousand | -44.53 Thousand |
| Free Cash Flow | -131.17 Thousand | -58.88 Thousand | -131.32 Thousand | -481.05 Thousand | -95.96 Thousand | -9450.00 |
EDEN
ORDS
FOG
5237
600977
SEQUENT